Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Business & Regulation

Business & Regulation Drug Discovery

Trend Forecasting

How will the pharmaceutical landscape shape up in 2022? Industry experts share their predictions.

Business & Regulation COVID-19

Switching Gears

| Musa Kana

COVID-19 caused a shift in scientific research. But what happened to the research programs that existed before the pandemic hit?

Business & Regulation COVID-19

The Biggest Moments of 2021

The pharmaceutical industry experienced its fair share of challenges and success in 2021. We break down the sector's biggest moments here.

Business & Regulation COVID-19

Through the Fire

| Maryam Mahdi

How did pharma fare during 2021 and will the industry move forward as the pandemic continues to impact lives on a global scale?

Business & Regulation Business Practice

Inside the PenCycle Recycling Scheme

Novo Nordisk explains how its pilot scheme in the UK is helping to recycle injector pens.

Business & Regulation Packaging

Desert, Tundra, and Archipelago: a Vaccine Epic

What did the industry learn about logistics during COVID vaccine rollout, and how will it make sure nobody gets left behind?

Business & Regulation Bioprocessing - Single Use Systems

Top Pharma Headlines of 2022: The Story So Far

It’s been a busy start to the year for biopharma, with a plethora of new announcements.

Business & Regulation COVID-19

A View on the Future of R&D From the UK

| Maryam Mahdi

Pharma experts convened at the Pharmaceutical Industry Network Group’s annual conference to discuss the UK’s position in pharmaceutical innovation.

Business & Regulation Supply Chain

The Value of Dogged Determination

| Banks Bourne

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?

Business & Regulation Business Practice

Teva Takes Hit in New York Opioid Case

| Stephanie Sutton

After other defendants in the case settle, Teva is left to face the music in New York alone.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine